BIO announces election of Ron Cohen, MD, President and CEO, Acorda Therapeutics, as new Chair of its Board of Directors for 2015-2016 term, and election of Deborah Dunsire, MD, President and CEO, FORUM Pharmaceuticals, as its new Board Secretary. BIO also announces re-election of Dan Junius, President and CEO, ImmunoGen, as Board Treasurer, and election of 19 Directors to serve on BIO’s Board Executive Committee. In addition, BIO welcomes 8 new members to its Board of Directors.